43 results
Page 2 of 3
8-K
EX-99.1
dm2yw yoyh
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
424B5
6l83c0l h5
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
8p3hqha9v5d
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
8-K
EX-99.1
vggp432fwbphqspu
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
424B5
7ipf5at
15 Apr 20
Prospectus supplement for primary offering
4:16pm
424B5
94cn6cbeo15dzebgu
14 Apr 20
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
3yy1sck
12 Nov 19
Crinetics Pharmaceuticals Reports Third Quarter 2019
4:01pm
S-3/A
ij6bipl5lg2
19 Aug 19
Shelf registration (amended)
4:17pm
S-3
f0vfk
13 Aug 19
Shelf registration
4:36pm
8-K
EX-99.1
1fefvsbe nz1fs
13 Aug 19
Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
xvv6wqz214i9ng 04p
16 Jul 19
Crinetics Pharmaceuticals Appoints Stephanie Okey to Board of Directors
9:00am
DEF 14A
d1v3mwm3y7n 357q3
29 Apr 19
Definitive proxy
12:00am
10-K
cd2q56u8j
13 Mar 19
Annual report
4:06pm
8-K
EX-99.1
xpsoq9d l4sy74i
1 Oct 18
Regulation FD Disclosure
4:01pm
424B4
fw0x32r19tjdsk4bi
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
22aqn551ximc
9 Jul 18
IPO registration (amended)
6:10am